Cargando…
The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis
BACKGROUND: Cardiac sarcoidosis (CS) diagnosis is usually based on advanced imaging techniques and multidisciplinary evaluation. Diagnosis is classified as definite, probable, possible or unlikely. If diagnostic confidence remains uncertain, cardiac imaging can be repeated. The objective is to evalu...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688603/ https://www.ncbi.nlm.nih.gov/pubmed/34928457 http://dx.doi.org/10.1186/s13550-021-00870-y |
_version_ | 1784618385145856000 |
---|---|
author | Mathijssen, H. Tjoeng, T. W. H. Keijsers, R. G. M. Bakker, A. L. M. Akdim, F. van Es, H. W. van Beek, F. T. Veltkamp, M. V. Grutters, J. C. Post, M. C. |
author_facet | Mathijssen, H. Tjoeng, T. W. H. Keijsers, R. G. M. Bakker, A. L. M. Akdim, F. van Es, H. W. van Beek, F. T. Veltkamp, M. V. Grutters, J. C. Post, M. C. |
author_sort | Mathijssen, H. |
collection | PubMed |
description | BACKGROUND: Cardiac sarcoidosis (CS) diagnosis is usually based on advanced imaging techniques and multidisciplinary evaluation. Diagnosis is classified as definite, probable, possible or unlikely. If diagnostic confidence remains uncertain, cardiac imaging can be repeated. The objective is to evaluate the usefulness of repeated cardiac magnetic resonance imaging (CMR) and fluorodeoxyglucose positron emission tomography (FDG PET/CT) for CS diagnosis in patients with an initial “possible” CS diagnosis. METHODS: We performed a retrospective cohort study in 35 patients diagnosed with possible CS by our multidisciplinary team (MDT), who received repeated CMR and FDG PET/CT within 12 months after diagnosis. Imaging modalities were scored on abnormalities suggestive for CS and classified as CMR+/PET+, CMR+/PET−, CMR−/PET+ and CMR−/PET−. Primary endpoint was final MDT diagnosis of CS. RESULTS: After re-evaluation, nine patients (25.7%) were reclassified as probable CS and 16 patients (45.7%) as unlikely CS. Two patients started immunosuppressive treatment after re-evaluation. At baseline, eleven patients (31.4%) showed late gadolinium enhancement (LGE) on CMR (CMR+) and 26 (74.3%) patients showed myocardial FDG-uptake (PET+). At re-evaluation, nine patients (25.7%) showed LGE (CMR+), while 16 patients (45.7%) showed myocardial FDG-uptake (PET+). When considering both imaging modalities together, 82.6% of patients with CMR−/PET+ at baseline were reclassified as possible or unlikely CS, while 36.4% of patients with CMR+ at baseline were reclassified as probable CS. Three patients with initial CMR−/PET+ showed LGE at re-evaluation. CONCLUSION: Repeated CMR and FDG PET/CT may be useful in establishing or rejecting CS diagnosis, when initial diagnosis is uncertain. However, clinical relevance has to be further determined. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13550-021-00870-y. |
format | Online Article Text |
id | pubmed-8688603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-86886032022-01-05 The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis Mathijssen, H. Tjoeng, T. W. H. Keijsers, R. G. M. Bakker, A. L. M. Akdim, F. van Es, H. W. van Beek, F. T. Veltkamp, M. V. Grutters, J. C. Post, M. C. EJNMMI Res Original Research BACKGROUND: Cardiac sarcoidosis (CS) diagnosis is usually based on advanced imaging techniques and multidisciplinary evaluation. Diagnosis is classified as definite, probable, possible or unlikely. If diagnostic confidence remains uncertain, cardiac imaging can be repeated. The objective is to evaluate the usefulness of repeated cardiac magnetic resonance imaging (CMR) and fluorodeoxyglucose positron emission tomography (FDG PET/CT) for CS diagnosis in patients with an initial “possible” CS diagnosis. METHODS: We performed a retrospective cohort study in 35 patients diagnosed with possible CS by our multidisciplinary team (MDT), who received repeated CMR and FDG PET/CT within 12 months after diagnosis. Imaging modalities were scored on abnormalities suggestive for CS and classified as CMR+/PET+, CMR+/PET−, CMR−/PET+ and CMR−/PET−. Primary endpoint was final MDT diagnosis of CS. RESULTS: After re-evaluation, nine patients (25.7%) were reclassified as probable CS and 16 patients (45.7%) as unlikely CS. Two patients started immunosuppressive treatment after re-evaluation. At baseline, eleven patients (31.4%) showed late gadolinium enhancement (LGE) on CMR (CMR+) and 26 (74.3%) patients showed myocardial FDG-uptake (PET+). At re-evaluation, nine patients (25.7%) showed LGE (CMR+), while 16 patients (45.7%) showed myocardial FDG-uptake (PET+). When considering both imaging modalities together, 82.6% of patients with CMR−/PET+ at baseline were reclassified as possible or unlikely CS, while 36.4% of patients with CMR+ at baseline were reclassified as probable CS. Three patients with initial CMR−/PET+ showed LGE at re-evaluation. CONCLUSION: Repeated CMR and FDG PET/CT may be useful in establishing or rejecting CS diagnosis, when initial diagnosis is uncertain. However, clinical relevance has to be further determined. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13550-021-00870-y. Springer Berlin Heidelberg 2021-12-20 /pmc/articles/PMC8688603/ /pubmed/34928457 http://dx.doi.org/10.1186/s13550-021-00870-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Research Mathijssen, H. Tjoeng, T. W. H. Keijsers, R. G. M. Bakker, A. L. M. Akdim, F. van Es, H. W. van Beek, F. T. Veltkamp, M. V. Grutters, J. C. Post, M. C. The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis |
title | The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis |
title_full | The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis |
title_fullStr | The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis |
title_full_unstemmed | The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis |
title_short | The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis |
title_sort | usefulness of repeated cmr and fdg pet/ct in the diagnosis of patients with initial possible cardiac sarcoidosis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688603/ https://www.ncbi.nlm.nih.gov/pubmed/34928457 http://dx.doi.org/10.1186/s13550-021-00870-y |
work_keys_str_mv | AT mathijssenh theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT tjoengtwh theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT keijsersrgm theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT bakkeralm theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT akdimf theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT vaneshw theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT vanbeekft theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT veltkampmv theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT gruttersjc theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT postmc theusefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT mathijssenh usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT tjoengtwh usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT keijsersrgm usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT bakkeralm usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT akdimf usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT vaneshw usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT vanbeekft usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT veltkampmv usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT gruttersjc usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis AT postmc usefulnessofrepeatedcmrandfdgpetctinthediagnosisofpatientswithinitialpossiblecardiacsarcoidosis |